Pravastatin/Fenofibrate Combination Therapy
Press Releases:
Sciele Completes Enrollment of Patients in Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
Sciele Begins to Enroll Patients in a Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
Sciele Pharma Signs a Development and Marketing Agreement for a Novel Combination of Fenofibrate and Pravastatin to Treat Mixed Dyslipidemia
Presentations:


Adobe® Reader® is required to view our Prescribing Information
documents;
click here to download this free program.
This web site and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.